Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Praecis seeks FDA approval of abarelix depot for prostate cancer

Dec. 15, 2000

Roche presents new antitumor agents acting on cyclin-dependent kinases

Dec. 14, 2000

Angstrom receives SBIR grant for development of uPAR antagonist

Dec. 14, 2000

Zycos begins phase II trial for treatment of cervical dysplasia

Dec. 14, 2000

Nonpeptide cathepsin D inhibitors identified at U. of California

Dec. 12, 2000

GSAO, a novel molecule with the potential to take on both cancer and HIV

Dec. 12, 2000

Phase II clinical trial of 2ME2 commences at Mayo Clinic

Dec. 12, 2000

Myriad Genetics obtains license to cancer drug in phase II

Dec. 12, 2000

Early clinical results for bryostatin 1 in hematological malignancies encouraging

Dec. 12, 2000

Cyclacel and CV Therapeutics join forces to screen anticancer compounds

Dec. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026